Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $7,715 - $8,859
-298 Reduced 3.59%
8,002 $222,000
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $391 - $509
-15 Reduced 0.18%
8,300 $238,000
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $994 - $1,162
-31 Reduced 0.37%
8,315 $275,000
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $6,321 - $7,313
-175 Reduced 2.05%
8,346 $306,000
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $14,653 - $19,076
-372 Reduced 4.18%
8,521 $347,000
Q4 2022

Jan 18, 2023

SELL
$41.75 - $54.5 $2,713 - $3,542
-65 Reduced 0.73%
8,893 $0
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $481 - $587
11 Added 0.12%
8,958 $392,000
Q2 2022

Jul 11, 2022

BUY
$46.53 - $55.17 $5,583 - $6,620
120 Added 1.36%
8,947 $469,000
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $4,986 - $6,179
109 Added 1.25%
8,827 $457,000
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $123 - $183
3 Added 0.03%
8,718 $515,000
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $2,551 - $3,277
-65 Reduced 0.74%
8,715 $375,000
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $39,500 - $44,748
-1,100 Reduced 11.13%
8,780 $344,000
Q1 2021

Apr 19, 2021

SELL
$33.49 - $37.77 $9,779 - $11,028
-292 Reduced 2.87%
9,880 $358,000
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $836 - $1,064
25 Added 0.25%
10,172 $374,000
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $26,733 - $31,364
-842 Reduced 7.66%
10,147 $372,000
Q2 2020

Jul 16, 2020

SELL
$30.12 - $36.54 $3,463 - $4,202
-115 Reduced 1.04%
10,989 $359,000
Q1 2020

Apr 23, 2020

SELL
$27.03 - $38.62 $3,676 - $5,252
-136 Reduced 1.21%
11,104 $410,000
Q4 2019

Apr 23, 2020

BUY
$32.92 - $37.36 $370,020 - $419,926
11,240 New
11,240 $440,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Affinity Capital Advisors, LLC Portfolio

Follow Affinity Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Capital Advisors, LLC with notifications on news.